Atlas Trials

Effects of Insulin Glargine and Lixisenatide on the Brain

Clinical trial NCT03881995 · TERMINATED

Trial details

NCT number
NCT03881995
Sponsor
University Hospital Tuebingen
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2019-03-18
Primary completion
2020-06-29
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.